Cetera Investment Advisers’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.4M | Sell |
248,891
-2,304
| -0.9% | -$161K | 0.03% | 573 |
|
|
2025
Q1 | $18.5M | Buy |
251,195
+56,449
| +29% | +$4.15M | 0.04% | 495 |
|
|
2024
Q4 | $12.8M | Sell |
194,746
-5,105
| -3% | -$334K | 0.03% | 610 |
|
|
2024
Q3 | $15.6M | Sell |
199,851
-2,482
| -1% | -$193K | 0.03% | 510 |
|
|
2024
Q2 | $15.8M | Sell |
202,333
-5,164
| -2% | -$403K | 0.04% | 470 |
|
|
2024
Q1 | $14.1M | Buy |
207,497
+148,042
| +249% | +$10M | 0.03% | 521 |
|
|
2023
Q4 | $4M | Buy |
59,455
+9,155
| +18% | +$617K | 0.03% | 514 |
|
|
2023
Q3 | $3.41M | Sell |
50,300
-4,637
| -8% | -$314K | 0.03% | 549 |
|
|
2023
Q2 | $3.93M | Sell |
54,937
-5,265
| -9% | -$377K | 0.03% | 494 |
|
|
2023
Q1 | $4.18M | Buy |
60,202
+4,819
| +9% | +$334K | 0.04% | 452 |
|
|
2022
Q4 | $3.75M | Sell |
55,383
-28,711
| -34% | -$1.95M | 0.03% | 477 |
|
|
2022
Q3 | $5K | Buy |
84,094
+32,054
| +62% | +$1.91K | ﹤0.01% | 1671 |
|
|
2022
Q2 | $3.44M | Sell |
52,040
-6,107
| -11% | -$403K | 0.05% | 339 |
|
|
2022
Q1 | $3.86M | Sell |
58,147
-4,027
| -6% | -$267K | 0.06% | 345 |
|
|
2021
Q4 | $3.62M | Sell |
62,174
-3,336
| -5% | -$194K | 0.05% | 374 |
|
|
2021
Q3 | $3.94M | Buy |
65,510
+8,047
| +14% | +$483K | 0.06% | 321 |
|
|
2021
Q2 | $3.44M | Buy |
57,463
+10,514
| +22% | +$630K | 0.06% | 359 |
|
|
2021
Q1 | $2.33M | Sell |
46,949
-1,693
| -3% | -$84.2K | 0.05% | 382 |
|
|
2020
Q4 | $2.43M | Buy |
48,642
+42,318
| +669% | +$2.12M | 0.05% | 382 |
|
|
2020
Q3 | $347K | Buy |
+6,324
| New | +$347K | 0.03% | 465 |
|